⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBRX News
Moleculin Biotech, Inc.
Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine
globenewswire.com
MBRX
Form 8-K
sec.gov
MBRX
Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR
globenewswire.com
MBRX
Form 8-K
sec.gov
MBRX
Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040
globenewswire.com
MBRX
Form 8-K
sec.gov
MBRX
Form 8-K
sec.gov
MBRX
Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings
globenewswire.com
MBRX
Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand
globenewswire.com
MBRX
Jennifer Stewart, CEO of Syntax Strategic, Named a 2026 Canada’s Most Powerful Women: Top 100 Award Winner
globenewswire.com
MBRX